Clearside Biomedical, Inc.
CLSDQ · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2025
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Thorp Clay: Form 4
Insider disclosure · Filed · Report period 24 Feb 2025
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
No linked security history is available yet.
Company details and SEC sources
CIK 0001539029 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CLSDQ on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 900 North Point Parkway, Suite 200, Alpharetta, GA, 30005
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields